Blockbuster AstraZeneca-Fusion Pharmaceuticals announcement shows Hamilton’s life science innovation ecosystem is thriving.
With support from the Government of Canada, Innovation Factory launches the Canadian Medtech Alliance (CAMEDA) program.
The 2022 Cluster Report summarizes the dynamic growth of the Hamilton life sciences ecosystem, highlighting the integration of organizations that contribute to its vibrant community.
Innovation Factory announces an MOU with HaloHealth to deliver a collaborative medical assessment & physician advisory service to SOPHIE companies.
Altis Labs announces today that it is leading an international coalition focused on the development and implementation of digital twins in clinical trials.
LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance through Newswire on June 14, 2023. Read the original […]
This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is a Bispecific Targeted Alpha Therapy (TAT) designed to Precisely Deliver Radiation to Tumor Cells HAMILTON, ON and BOSTON, April 12, 2023 /– Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision […]
Hamilton, ON – March 23, 2023 – Yesterday, Innovation Factory’s Synapse Life Science Competition, Ontario’s premier life science pitch competition, announced the winners of over $100,000 in prizes at the 10th annual showcase event. After three years of virtual events, the competition was held in person for the first time since 2019, bringing together innovators, […]
This media release was originally published by Altis Labs on January 24, 2023. Toronto, Ontario – Altis Labs, Inc. (“Altis”), the computational imaging platform for advancing precision medicine, announces today an initiative focused on developing, validating, and commercializing fully automated imaging biomarkers for solid tumors using deep learning. Led by Altis, the initiative leverages a […]